Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?

We report on a 72-year-old male patient who developed sarcoidosis of the mediastinal lymph nodes, the liver, and the prostate 11 years ago. Seven years later, he underwent transurethral resection of the prostate by laser due to hematuria. Pathology of the resected chips showed a ‘granulomatous prost...

Full description

Bibliographic Details
Main Authors: Robert M. Hermann, Manoutschehr Djannatian, Norbert Czech, Mirko Nitsche
Format: Article
Language:English
Published: Karger Publishers 2016-08-01
Series:Case Reports in Oncology
Subjects:
Online Access:http://www.karger.com/Article/FullText/447688
_version_ 1819292017287495680
author Robert M. Hermann
Manoutschehr Djannatian
Norbert Czech
Mirko Nitsche
author_facet Robert M. Hermann
Manoutschehr Djannatian
Norbert Czech
Mirko Nitsche
author_sort Robert M. Hermann
collection DOAJ
description We report on a 72-year-old male patient who developed sarcoidosis of the mediastinal lymph nodes, the liver, and the prostate 11 years ago. Seven years later, he underwent transurethral resection of the prostate by laser due to hematuria. Pathology of the resected chips showed a ‘granulomatous prostatitis with epitheloid cells’. Malignancy was histologically excluded at that time. Four years later, he was diagnosed with an undifferentiated prostate carcinoma, with a Gleason score of 5 + 4 = 9. After initiation of antihormonal therapy, he underwent radical prostatectomy and pelvic lymphadenectomy, which revealed a pT3b pN1 carcinoma with infiltrated resection margins. Three months later, the prostate-specific antigen level was 1.4 ng/ml, and a local recurrence was suspected by ultrasound; consequently, a 68Ga-prostate-specific membrane antigen (PSMA) PET/CT was performed. This examination seemed to confirm the local recurrence, a right pelvic lymph node metastasis, and a hepatic metastasis. However, ultrasound with contrast medium could not confirm the metastatic spread to the liver. In palliative intention, radiotherapy of the pelvis was done. After 50 Gy, the supposed recurrence had markedly shrunk, and an additional boost dose with 16.2 Gy was applied. Two years later, the patient is still free of disease. Due to this clinical development, we doubt the diagnosis of a fulminant progression of the prostate cancer as suspected by PSMA-PET/CT. Instead, we suspect a recurrence of the previously proven sarcoidosis leading to false-positive results. Our focus in this report is on the interaction between PSMA-PET/CT and sarcoidosis. Another report on a case of sarcoidosis of the spleen seems to confirm this possibility [Kobe et al: Clin Nucl Med 2015;40: 897–898].
first_indexed 2024-12-24T03:47:50Z
format Article
id doaj.art-bcb167ca6047494ab7f246f8c6bc5f3b
institution Directory Open Access Journal
issn 1662-6575
language English
last_indexed 2024-12-24T03:47:50Z
publishDate 2016-08-01
publisher Karger Publishers
record_format Article
series Case Reports in Oncology
spelling doaj.art-bcb167ca6047494ab7f246f8c6bc5f3b2022-12-21T17:16:39ZengKarger PublishersCase Reports in Oncology1662-65752016-08-019245746310.1159/000447688447688Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?Robert M. HermannManoutschehr DjannatianNorbert CzechMirko NitscheWe report on a 72-year-old male patient who developed sarcoidosis of the mediastinal lymph nodes, the liver, and the prostate 11 years ago. Seven years later, he underwent transurethral resection of the prostate by laser due to hematuria. Pathology of the resected chips showed a ‘granulomatous prostatitis with epitheloid cells’. Malignancy was histologically excluded at that time. Four years later, he was diagnosed with an undifferentiated prostate carcinoma, with a Gleason score of 5 + 4 = 9. After initiation of antihormonal therapy, he underwent radical prostatectomy and pelvic lymphadenectomy, which revealed a pT3b pN1 carcinoma with infiltrated resection margins. Three months later, the prostate-specific antigen level was 1.4 ng/ml, and a local recurrence was suspected by ultrasound; consequently, a 68Ga-prostate-specific membrane antigen (PSMA) PET/CT was performed. This examination seemed to confirm the local recurrence, a right pelvic lymph node metastasis, and a hepatic metastasis. However, ultrasound with contrast medium could not confirm the metastatic spread to the liver. In palliative intention, radiotherapy of the pelvis was done. After 50 Gy, the supposed recurrence had markedly shrunk, and an additional boost dose with 16.2 Gy was applied. Two years later, the patient is still free of disease. Due to this clinical development, we doubt the diagnosis of a fulminant progression of the prostate cancer as suspected by PSMA-PET/CT. Instead, we suspect a recurrence of the previously proven sarcoidosis leading to false-positive results. Our focus in this report is on the interaction between PSMA-PET/CT and sarcoidosis. Another report on a case of sarcoidosis of the spleen seems to confirm this possibility [Kobe et al: Clin Nucl Med 2015;40: 897–898].http://www.karger.com/Article/FullText/447688Prostate-specific membrane antigenRadiotherapyProstate cancerSarcoidosisPET/CT
spellingShingle Robert M. Hermann
Manoutschehr Djannatian
Norbert Czech
Mirko Nitsche
Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?
Case Reports in Oncology
Prostate-specific membrane antigen
Radiotherapy
Prostate cancer
Sarcoidosis
PET/CT
title Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?
title_full Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?
title_fullStr Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?
title_full_unstemmed Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?
title_short Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?
title_sort prostate specific membrane antigen pet ct false positive results due to sarcoidosis
topic Prostate-specific membrane antigen
Radiotherapy
Prostate cancer
Sarcoidosis
PET/CT
url http://www.karger.com/Article/FullText/447688
work_keys_str_mv AT robertmhermann prostatespecificmembraneantigenpetctfalsepositiveresultsduetosarcoidosis
AT manoutschehrdjannatian prostatespecificmembraneantigenpetctfalsepositiveresultsduetosarcoidosis
AT norbertczech prostatespecificmembraneantigenpetctfalsepositiveresultsduetosarcoidosis
AT mirkonitsche prostatespecificmembraneantigenpetctfalsepositiveresultsduetosarcoidosis